Evidence map›Paper›PMID 38659913›Full record

ArticlebioRxiv : the preprint server for biology2024

Tumorigenesis driven by the BRAF

Sunyana Gadal, Jacob A Boyer, Simon F Roy, Noah A Outmezguine, Malvika Sharma, Hongyan Li, Ning Fan, Eric Chan, Yevgeniy Romin, Afsar Barlas and 9 more

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 2 countries.

Sunyana GadalMolecular Pharmacology Program, Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA.
Jacob A BoyerLudwig Institute for Cancer Research, Princeton University, Princeton, NJ 08544, USA.
Simon F RoyDepartment of Dermatology, Yale University, New Haven, CT 06510, USA.
Noah A OutmezguineMolecular Pharmacology Program, Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA.
Malvika SharmaMolecular Pharmacology Program, Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA.
Hongyan LiAntitumor Assessment Core Facility, Molecular Pharmacology Program, MSKCC, New York, NY 10065, USA.
Ning FanMolecular Cytology Core, MSKCC, New York, NY 10065, USA.
Eric ChanMolecular Cytology Core, MSKCC, New York, NY 10065, USA.
Yevgeniy RominMolecular Cytology Core, MSKCC, New York, NY 10065, USA.
Afsar BarlasMolecular Cytology Core, MSKCC, New York, NY 10065, USA.
Qing ChangAntitumor Assessment Core Facility, Molecular Pharmacology Program, MSKCC, New York, NY 10065, USA.
Priya PancholiMolecular Pharmacology Program, Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA.
Neilawattie Merna TimaulMolecular Pharmacology Program, Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA.
Michael OverholtzerCell Biology Program, MSKCC, New York, NY 10065, USA.
Rona YaegerDepartment of Medicine, MSKCC, New York, NY 10065, USA.
Katia Manova-TodorovaMolecular Cytology Core, MSKCC, New York, NY 10065, USA.
Elisa de StanchinaAntitumor Assessment Core Facility, Molecular Pharmacology Program, MSKCC, New York, NY 10065, USA.
Marcus BosenbergDepartment of Dermatology, Yale University, New Haven, CT 06510, USA.
Neal RosenMolecular Pharmacology Program, Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA.ORCID 0000-0002-8307-654X
Memorial Sloan Kettering Cancer Center · USYale University · USPrinceton University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
The Role of Focal Oncogene Amplifications in Lung CancerP01CA129243 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Andrea Ventura · 2007 to 2026
$31.2M
Studies on oncoprotein-induced feedback: Basic and therapeutic implicationsR35CA210085 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ROSEN, NEAL · 2016 to 2022
$7.3M
NCI NIH HHS P01 CA129243NCI NIH HHS P30 CA008748NCI NIH HHS R35 CA210085
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38659913
PMCPMC11042182
OpenAlexW4388879933

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.